Neurological Disorder Diagnostics Market 2028 By Technology, Diseases Indication, End-User | The Insight Partners

report image

Neurological Disorder Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Technology (Imaging, In Vitro Diagnostics); Diseases Indication (Genetic Neurological Disorders, Immunological Neurological Disorders, Paraneoplastic Syndrome, Paraproteinemic Neuropathies, Other Disease Indication); End-User (Hospitals & Clinics, Diagnostic Centers, Ambulatory Care Centers)

Report Code: TIPHE100001432 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming


Diagnostic tests are vital tools that help rule out or confirm the presence of neurological disorders among individuals facing specific symptoms. The advances in brain monitoring lead to living visualization of brain interior and live brain functions. This technology helps neurologists to diagnose neurological diseases with accuracy. Two techniques majorly accomplish the investigation of neurological disorders as imaging and in vitro diagnostics.


The "Global Neurological Disorder Diagnostics Market Analysis to 2028" is a specialized and in-depth study of the food and beverages industry with a special focus on the global market trend analysis. The report aims to provide an overview of the neurological disorder diagnostics market with detailed market segmentation by technology, diseases indication, end user, and geography. The report provides key statistics on the market status of the leading neurological disorder diagnostics market players and offers key trends and opportunities in the market.


  • Based on technology, the global neurological disorder diagnostics market is segmented into imaging, in vitro diagnostics.
  • Based on diseases indication, the market is bifurcated into genetic neurological disorders, immunological neurological disorders, paraneoplastic syndrome, paraproteinemic neuropathies, other disease indication.
  • Based on end user, the market is bifurcated into hospitals & clinics, diagnostic centers, ambulatory care centers.



  • Increasing prevalence of cerebral and neurological disorders such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis among others
  • Rapid growth in the geriatric population across the globe
  • New market players are entering the market owing to the technological advancement of products.


  • High costs of the imaging devices


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The neurological disorder diagnostics market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the neurological disorder diagnostics market in these regions.


COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.


The report covers key developments in the neurological disorder diagnostics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from neurological disorder diagnostics market are anticipated to lucrative growth opportunities in the future with the rising demand for neurological disorder diagnostics in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the neurological disorder diagnostics market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  • Siemens Healthineers
  • Koninklijke Philips N.V.
  • General Electric
  • Esaote SpA
  • Neurologica Corp.
  • Lifelines Neuro Company, LLC
  • Advanced Brain Monitoring
  • Nihon Kohden Corporation
  • Thermo Fisher Scientific, Inc.
  • Natus Medical Incorporated

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

The List of Companies

1. Siemens Healthineers
2. Koninklijke Philips N.V.
3. General Electric
4. Esaote SpA
5. Neurologica Corp.
6. Lifelines Neuro Company, LLC
7. Advanced Brain Monitoring
8. Nihon Kohden Corporation
9. Thermo Fisher Scientific, Inc.
10. Natus Medical Incorporated
11. Canon Medical Systems Corporation
12. Masimo Corporation
13. York Instruments Ltd.
14. Neusoft Medical Systems

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market

Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount